The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Infectious Disease Diagnostics-Global Market Insights and Sales Trends 2025

Infectious Disease Diagnostics-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1814762

No of Pages : 122

Ask Your Query

Synopsis

Infectious disease diagnostics are medical tests and assays used to identify infectious agents, such as bacteria, viruses, and parasites, in patient samples. They play a crucial role in early detection and effective management of infectious diseases.

The global Infectious Disease Diagnostics market size is expected to reach US$ 4776.2 million by 2029, growing at a CAGR of 4.3% from 2023 to 2029. The market is mainly driven by the significant applications of Infectious Disease Diagnostics in various end use industries. The expanding demands from the Hepatitis C, Hepatitis B, Tuberculosis (TB) and Acquired Immunodeficiency Syndrome (AIDS), are propelling Infectious Disease Diagnostics market. Molecular Diagnostic Technique, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Traditional Diagnostic Technique segment is estimated at % CAGR for the next seven-year period.

The market for infectious disease diagnostics is driven by the increasing prevalence of infectious diseases and the need for accurate and rapid diagnostic solutions to control disease outbreaks. The market's growth is also influenced by technological advancements, such as molecular diagnostics and point-of-care testing.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infectious Disease Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Infectious Disease Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Infectious Disease Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infectious Disease Diagnostics sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Infectious Disease Diagnostics covered in this report include Bio Mérieux SA, Roche Diagnostics, Abbott Laboratories, Thermo Fischer Scientific, BD, Bio-Rad Laboratories, Abbott, Danaher and Johnson and Johnson, etc.

The global Infectious Disease Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Bio Mérieux SA
  • Roche Diagnostics
  • Abbott Laboratories
  • Thermo Fischer Scientific
  • BD
  • Bio-Rad Laboratories
  • Abbott
  • Danaher
  • Johnson and Johnson
  • Guangzhou Wondfo Biotech Co.,Ltd.
  • Getein Biotech, Inc.
  • Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
  • BGI Genomics Co.,Ltd.
  • Maccura Biotechnology Co.,Ltd.
  • Daan Gene
  • Beijing Strong Biotechnologies,Inc
  • Shanghai Kehua Bio-Engineering Co.,Ltd.
  • Guangdong Hybribio Biotech Co.,Ltd.
  • Shanghai Runda Medical Technology Co.,Ltd.
  • Tellgen Corporation

Global Infectious Disease Diagnostics market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Infectious Disease Diagnostics market, Segment by Type:

  • Molecular Diagnostic Technique
  • Traditional Diagnostic Technique

Global Infectious Disease Diagnostics market, by Application

  • Hepatitis C
  • Hepatitis B
  • Tuberculosis (TB)
  • Acquired Immunodeficiency Syndrome (AIDS)
  • Human Papillomavirus (HPV)
  • Methicillin-resistant Staphylococcus Aureus (MRSA)

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Infectious Disease Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Infectious Disease Diagnostics
1.1 Infectious Disease Diagnostics Market Overview
1.1.1 Infectious Disease Diagnostics Product Scope
1.1.2 Infectious Disease Diagnostics Market Status and Outlook
1.2 Global Infectious Disease Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Infectious Disease Diagnostics Market Size by Region (2018-2029)
1.4 Global Infectious Disease Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Infectious Disease Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Infectious Disease Diagnostics Market Size (2018-2029)
1.6.1 North America Infectious Disease Diagnostics Market Size (2018-2029)
1.6.2 Europe Infectious Disease Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Infectious Disease Diagnostics Market Size (2018-2029)
1.6.4 Latin America Infectious Disease Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Infectious Disease Diagnostics Market Size (2018-2029)
2 Infectious Disease Diagnostics Market by Type
2.1 Introduction
2.1.1 Molecular Diagnostic Technique
2.1.2 Traditional Diagnostic Technique
2.2 Global Infectious Disease Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Infectious Disease Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Infectious Disease Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Infectious Disease Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Infectious Disease Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Infectious Disease Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Infectious Disease Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Infectious Disease Diagnostics Revenue Breakdown by Type (2018-2029)
3 Infectious Disease Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hepatitis C
3.1.2 Hepatitis B
3.1.3 Tuberculosis (TB)
3.1.4 Acquired Immunodeficiency Syndrome (AIDS)
3.1.5 Human Papillomavirus (HPV)
3.1.6 Methicillin-resistant Staphylococcus Aureus (MRSA)
3.2 Global Infectious Disease Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Infectious Disease Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Infectious Disease Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Infectious Disease Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Infectious Disease Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Infectious Disease Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Infectious Disease Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Infectious Disease Diagnostics Revenue Breakdown by Application (2018-2029)
4 Infectious Disease Diagnostics Competition Analysis by Players
4.1 Global Infectious Disease Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Infectious Disease Diagnostics as of 2022)
4.3 Date of Key Players Enter into Infectious Disease Diagnostics Market
4.4 Global Top Players Infectious Disease Diagnostics Headquarters and Area Served
4.5 Key Players Infectious Disease Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Infectious Disease Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bio Mérieux SA
5.1.1 Bio Mérieux SA Profile
5.1.2 Bio Mérieux SA Main Business
5.1.3 Bio Mérieux SA Infectious Disease Diagnostics Products, Services and Solutions
5.1.4 Bio Mérieux SA Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Bio Mérieux SA Recent Developments
5.2 Roche Diagnostics
5.2.1 Roche Diagnostics Profile
5.2.2 Roche Diagnostics Main Business
5.2.3 Roche Diagnostics Infectious Disease Diagnostics Products, Services and Solutions
5.2.4 Roche Diagnostics Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Diagnostics Recent Developments
5.3 Abbott Laboratories
5.3.1 Abbott Laboratories Profile
5.3.2 Abbott Laboratories Main Business
5.3.3 Abbott Laboratories Infectious Disease Diagnostics Products, Services and Solutions
5.3.4 Abbott Laboratories Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Thermo Fischer Scientific Recent Developments
5.4 Thermo Fischer Scientific
5.4.1 Thermo Fischer Scientific Profile
5.4.2 Thermo Fischer Scientific Main Business
5.4.3 Thermo Fischer Scientific Infectious Disease Diagnostics Products, Services and Solutions
5.4.4 Thermo Fischer Scientific Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Thermo Fischer Scientific Recent Developments
5.5 BD
5.5.1 BD Profile
5.5.2 BD Main Business
5.5.3 BD Infectious Disease Diagnostics Products, Services and Solutions
5.5.4 BD Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 BD Recent Developments
5.6 Bio-Rad Laboratories
5.6.1 Bio-Rad Laboratories Profile
5.6.2 Bio-Rad Laboratories Main Business
5.6.3 Bio-Rad Laboratories Infectious Disease Diagnostics Products, Services and Solutions
5.6.4 Bio-Rad Laboratories Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Bio-Rad Laboratories Recent Developments
5.7 Abbott
5.7.1 Abbott Profile
5.7.2 Abbott Main Business
5.7.3 Abbott Infectious Disease Diagnostics Products, Services and Solutions
5.7.4 Abbott Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Abbott Recent Developments
5.8 Danaher
5.8.1 Danaher Profile
5.8.2 Danaher Main Business
5.8.3 Danaher Infectious Disease Diagnostics Products, Services and Solutions
5.8.4 Danaher Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Danaher Recent Developments
5.9 Johnson and Johnson
5.9.1 Johnson and Johnson Profile
5.9.2 Johnson and Johnson Main Business
5.9.3 Johnson and Johnson Infectious Disease Diagnostics Products, Services and Solutions
5.9.4 Johnson and Johnson Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Johnson and Johnson Recent Developments
5.10 Guangzhou Wondfo Biotech Co.,Ltd.
5.10.1 Guangzhou Wondfo Biotech Co.,Ltd. Profile
5.10.2 Guangzhou Wondfo Biotech Co.,Ltd. Main Business
5.10.3 Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Products, Services and Solutions
5.10.4 Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments
5.11 Getein Biotech, Inc.
5.11.1 Getein Biotech, Inc. Profile
5.11.2 Getein Biotech, Inc. Main Business
5.11.3 Getein Biotech, Inc. Infectious Disease Diagnostics Products, Services and Solutions
5.11.4 Getein Biotech, Inc. Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 Getein Biotech, Inc. Recent Developments
5.12 Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
5.12.1 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Profile
5.12.2 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Main Business
5.12.3 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Products, Services and Solutions
5.12.4 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Recent Developments
5.13 BGI Genomics Co.,Ltd.
5.13.1 BGI Genomics Co.,Ltd. Profile
5.13.2 BGI Genomics Co.,Ltd. Main Business
5.13.3 BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Products, Services and Solutions
5.13.4 BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.13.5 BGI Genomics Co.,Ltd. Recent Developments
5.14 Maccura Biotechnology Co.,Ltd.
5.14.1 Maccura Biotechnology Co.,Ltd. Profile
5.14.2 Maccura Biotechnology Co.,Ltd. Main Business
5.14.3 Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Products, Services and Solutions
5.14.4 Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.14.5 Maccura Biotechnology Co.,Ltd. Recent Developments
5.15 Daan Gene
5.15.1 Daan Gene Profile
5.15.2 Daan Gene Main Business
5.15.3 Daan Gene Infectious Disease Diagnostics Products, Services and Solutions
5.15.4 Daan Gene Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.15.5 Daan Gene Recent Developments
5.16 Beijing Strong Biotechnologies,Inc
5.16.1 Beijing Strong Biotechnologies,Inc Profile
5.16.2 Beijing Strong Biotechnologies,Inc Main Business
5.16.3 Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Products, Services and Solutions
5.16.4 Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.16.5 Beijing Strong Biotechnologies,Inc Recent Developments
5.17 Shanghai Kehua Bio-Engineering Co.,Ltd.
5.17.1 Shanghai Kehua Bio-Engineering Co.,Ltd. Profile
5.17.2 Shanghai Kehua Bio-Engineering Co.,Ltd. Main Business
5.17.3 Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Products, Services and Solutions
5.17.4 Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.17.5 Shanghai Kehua Bio-Engineering Co.,Ltd. Recent Developments
5.18 Guangdong Hybribio Biotech Co.,Ltd.
5.18.1 Guangdong Hybribio Biotech Co.,Ltd. Profile
5.18.2 Guangdong Hybribio Biotech Co.,Ltd. Main Business
5.18.3 Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Products, Services and Solutions
5.18.4 Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.18.5 Guangdong Hybribio Biotech Co.,Ltd. Recent Developments
5.19 Shanghai Runda Medical Technology Co.,Ltd.
5.19.1 Shanghai Runda Medical Technology Co.,Ltd. Profile
5.19.2 Shanghai Runda Medical Technology Co.,Ltd. Main Business
5.19.3 Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Products, Services and Solutions
5.19.4 Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.19.5 Shanghai Runda Medical Technology Co.,Ltd. Recent Developments
5.20 Tellgen Corporation
5.20.1 Tellgen Corporation Profile
5.20.2 Tellgen Corporation Main Business
5.20.3 Tellgen Corporation Infectious Disease Diagnostics Products, Services and Solutions
5.20.4 Tellgen Corporation Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.20.5 Tellgen Corporation Recent Developments
6 North America
6.1 North America Infectious Disease Diagnostics Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Infectious Disease Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Infectious Disease Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Infectious Disease Diagnostics Market Dynamics
11.1 Infectious Disease Diagnostics Industry Trends
11.2 Infectious Disease Diagnostics Market Drivers
11.3 Infectious Disease Diagnostics Market Challenges
11.4 Infectious Disease Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock